Weekly cisplatin (40 mg/m2) versus three-weekly (100mg/m2) cisplatin delivered concurrently with radiotherapy in high risk head and neck cancer patients

2020 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Mahinour Bassiouny
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Weekly Cisplatin

The “rocky treatment course”: identifying a high-risk subgroup of head and neck cancer patients for supportive interventions

2016 ◽  
Vol 25 (3) ◽  
pp. 719-727 ◽  
Author(s):  
Horia Vulpe ◽  
Janet Ellis ◽  
Shao Hui Huang ◽  
Eshetu G. Atenafu ◽  
Raymond W. Jang ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Supportive Interventions

scholarly journals Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of India

PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0140700 ◽  
Author(s):  
Rupesh Kumar ◽  
Avdhesh Kumar Rai ◽  
Debabrata Das ◽  
Rajjyoti Das ◽  
R. Suresh Kumar ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Hpv Infection ◽  
North East ◽  
East Region ◽  
High Risk Hpv

scholarly journals High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV

2016 ◽  
Vol 15 (2) ◽  
pp. 179-188 ◽  
Author(s):  
Heather M. Walline ◽  
Thomas E. Carey ◽  
Christine M. Goudsmit ◽  
Emily L. Bellile ◽  
Gypsyamber D'Souza ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
High Risk Hpv

scholarly journals 2863 A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer

2015 ◽  
Vol 51 ◽  
pp. S577
Author(s):  
S.F. Oosting ◽  
T.W.W. Chen ◽  
S.H.H. Huang ◽  
L. Wang ◽  
J. Waldron ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Neck Cancer ◽  
Adjuvant Radiotherapy ◽  
Weekly Cisplatin

Sonic Hedgehog (SHH) Status Determines the Chemotherapeutic Outcomes in High Risk Stage II and III Head and Neck Cancer Patients

2018 ◽  
Author(s):  
Abu Shadat M Noman ◽  
Rashed R Parag ◽  
Irfanur Rashid ◽  
Zillur Rahman ◽  
Ali Asgar Chowdhury ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Cancer Patients ◽  
Sonic Hedgehog ◽  
Neck Cancer ◽  
Stage Ii

A Phase II Multi-institutional Trial of Chemoradiation Using Weekly Docetaxel and Erythropoietin for High-Risk Postoperative Head and Neck Cancer Patients

2007 ◽  
Vol 67 (5) ◽  
pp. 1323-1331 ◽  
Author(s):  
Christopher D. Willey ◽  
Barbara A. Murphy ◽  
James L. Netterville ◽  
Brian B. Burkey ◽  
Yu Shyr ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
High Risk ◽  
Head And Neck ◽  
Cancer Patients ◽  
Phase Ii ◽  
Neck Cancer ◽  
Weekly Docetaxel
Sign in / Sign up

Export Citation Format

Share Document